Download by
Scanning QR Code
CN Stock MarketDetailed Quotes
002022 Shanghai Kehua Bio-engineering
Watchlist
9.02
+0.11+1.23%
Market Closed 09/22 15:00 CST
9.04High8.81Low34.73KlotVolume
8.91Open8.91Pre Close30.95MTurnover0.68%Turnover Ratio4.90P/E (TTM)4.64BMarket Cap13.8252wk High4.78P/E (Static)514.30MShares8.5252wk Low1.05P/B4.64BFloat Cap62.49Historical High9.80Limit Up514.14MShs Float-1.78Historical Low8.02Limit Down2.58%Amplitude15.47KlotAsk0.60Dividend TTM8.91Avg Price19.24KlotBid6.65%Div YieldTTM100Lot Size
Shanghai Kehua Bio-engineering Key Stats
All
YOY
| (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | (Q3)2022/03/31 | (FY)2021/12/31 | (Q9)2021/09/30 | (Q6)2021/06/30 | (Q3)2021/03/31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 42.82%1.39B | 57.31%749.8M | 47.62%7.4B | 47.04%5.42B | -59.94%970.19M | -66.86%476.64M | 8.52%5.01B | 31.61%3.68B | 43.13%2.42B | 128.33%1.44B |
| Refunds of taxes and levies | 7,984.86%36.94M | 2,152.65%9.23M | 287.75%179.54M | 131.01%70.76M | -97.47%456.85K | -94.01%409.56K | 108.77%46.3M | 526.30%30.63M | 585.90%18.04M | 266.88%6.84M |
| Cash received relating to other operating activities | 337.60%33.07M | 325.89%15.25M | 329.16%279.98M | 155.01%92.43M | -74.99%7.56M | -72.48%3.58M | -28.49%65.24M | 34.31%36.24M | 62.80%30.22M | -66.78%13.01M |
| Cash inflows from operating activities | 48.81%1.46B | 61.10%774.28M | 53.38%7.86B | 48.77%5.58B | -60.39%978.2M | -67.04%480.63M | 8.28%5.12B | 32.49%3.75B | 44.18%2.47B | 117.32%1.46B |
| Goods services cash paid | 94.75%1.08B | 135.97%627.29M | 40.32%3.48B | 41.10%2.55B | -52.83%554.68M | -59.66%265.84M | 13.18%2.48B | 33.51%1.81B | 30.25%1.18B | 77.96%659M |
| Staff behalf paid | 180.36%510.5M | 223.65%303.97M | 37.50%710.15M | 25.34%499.58M | -39.15%182.09M | -45.51%93.92M | 44.61%516.47M | 52.99%398.57M | 67.49%299.25M | 71.37%172.36M |
| All taxes paid | 513.50%154.65M | 257.82%76.84M | 56.19%866.12M | 56.26%681.72M | -92.18%25.21M | -88.31%21.47M | 62.08%554.51M | 103.25%436.27M | 198.22%322.31M | 343.89%183.77M |
| Cash paid relating to other operating activities | 72.46%302.28M | 101.55%174.93M | 31.36%644.55M | 9.60%373.21M | -19.66%175.28M | -4.37%86.79M | 4.00%490.66M | 33.25%340.53M | 5.18%218.18M | -12.05%90.76M |
| Cash outflows from operating activities | 118.48%2.05B | 152.77%1.18B | 41.05%5.7B | 37.62%4.11B | -53.50%937.25M | -57.68%468.02M | 20.21%4.04B | 43.09%2.98B | 44.28%2.02B | 79.68%1.11B |
| Net cash flows from operating activities | -1,545.77%-592.06M | -3,341.59%-408.75M | 99.55%2.15B | 92.17%1.47B | -90.99%40.95M | -96.42%12.61M | -21.06%1.08B | 2.86%766.95M | 43.70%454.29M | 535.18%352.21M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | ---- | ---- | ---- | ---- | ---- | -93.83%1.23M | ---- | ---- | ---- |
| Cash received from returns on investments | ---- | ---- | ---- | ---- | ---- | ---- | 245.33%239.05K | 0.00%69.23K | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 328.25%1.41M | 260.71%1.17M | 207.27%22.3M | -87.39%445.12K | -87.87%328.76K | -87.72%324.7K | -51.47%7.26M | -50.08%3.53M | -60.74%2.71M | 475,855.86%2.64M |
| Cash received relating to other investing activities | --14.85M | --7.44M | -21.07%3.9M | ---- | ---- | ---- | 259.94%4.94M | --5.42M | --4.04M | --1.51M |
| Cash inflows from investing activities | 4,845.67%16.26M | 2,550.71%8.61M | 91.64%26.2M | -95.06%445.12K | -95.13%328.76K | -92.18%324.7K | -62.44%13.67M | -66.78%9.02M | -74.91%6.75M | 746,934.85%4.15M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 157.82%162.22M | 170.38%72.59M | 98.08%427.91M | 30.16%230.18M | -50.57%62.92M | -46.45%26.85M | -16.18%216.03M | -9.94%176.84M | 0.46%127.28M | -34.69%50.14M |
| Cash paid to acquire investments | ---- | ---- | -39.64%6.12M | ---- | ---- | ---- | -59.20%10.14M | -59.20%10.14M | ---- | ---- |
| Cash outflows from investing activities | 157.82%162.22M | 170.38%72.59M | 91.91%434.03M | 23.10%230.18M | -50.57%62.92M | -46.45%26.85M | -19.96%226.17M | -15.48%186.98M | -4.95%127.28M | -34.69%50.14M |
| Net cash flows from investing activities | -133.20%-145.96M | -141.24%-63.98M | -91.92%-407.82M | -29.09%-229.74M | 48.07%-62.59M | 42.32%-26.52M | 13.68%-212.49M | 8.30%-177.96M | -12.64%-120.53M | 40.10%-45.99M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | -35.01%4.9M | -28.53%3.7M | -40.89%3M | -80.27%697.03K | -98.96%7.54M | 56.39%5.17M | 166.77%5.07M | 103.04%3.53M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | 71.43%4.2M | 22.45%3M | -6.12%2.3M | ---- | --2.45M | --2.45M | --2.45M | --980K |
| Cash from borrowing | 106.69%108.7M | 254.14%34.06M | -40.75%159.53M | -41.60%59.94M | -39.22%52.59M | -81.04%9.62M | -53.43%269.23M | -92.18%102.64M | -67.09%86.53M | -40.54%50.71M |
| Cash received relating to other financing activities | ---- | ---- | 21,834.42%149.15M | --138.75M | ---- | ---- | 35.32%680K | ---- | ---- | ---- |
| Cash inflows from financing activities | 95.55%108.7M | 230.21%34.06M | 13.02%313.58M | 87.73%202.39M | -39.32%55.58M | -80.99%10.31M | -78.73%277.45M | -91.80%107.81M | -65.41%91.6M | -37.67%54.24M |
| Borrowing repayment | -9.38%76.37M | -23.45%30.76M | -62.78%198.74M | -84.20%75.11M | -82.29%84.27M | -79.54%40.17M | -12.05%533.9M | -17.61%475.3M | 397.02%475.97M | 582.14%196.4M |
| Dividend interest payment | 2,017.26%486.3M | 10,269.07%169.67M | 625.12%854.8M | -38.88%69.29M | 114.51%22.97M | -82.65%1.64M | 30.23%117.88M | 109.28%113.38M | -12.19%10.71M | 61.56%9.43M |
| -Including:Cash payments for dividends or profit to minority shareholders | --177.5M | --168.5M | --801.22M | --27.52M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 381.11%38.65M | 58.05%2.24M | -80.61%35.19M | 77.12%12.59M | 381.62%8.03M | --1.42M | 1,969.10%181.45M | 109.15%7.11M | --1.67M | ---- |
| Cash outflows from financing activities | 421.65%601.32M | 368.82%202.67M | 30.66%1.09B | -73.65%156.99M | -76.40%115.27M | -79.00%43.23M | 17.96%833.23M | -6.10%595.78M | 352.35%488.35M | 494.37%205.83M |
| Net cash flows from financing activities | -725.33%-492.63M | -412.25%-168.61M | -39.47%-775.14M | 109.30%45.4M | 84.96%-59.69M | 78.29%-32.92M | -192.95%-555.78M | -171.68%-487.97M | -352.92%-396.75M | -389.37%-151.59M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 229.45%1.61M | -1,044.19%-10.82M | 626.78%51.56M | 2,741.16%91.14M | 71.43%-1.24M | 40.83%-945.55K | -2.86%-9.79M | -51.69%-3.45M | -475.78%-4.35M | -45,254.00%-1.6M |
| Net increase in cash and cash equivalents | -1,388.48%-1.23B | -1,265.07%-652.16M | 239.44%1.02B | 1,315.09%1.38B | -22.60%-82.57M | -131.22%-47.78M | -82.38%301.15M | -92.07%97.57M | -118.34%-67.35M | 392.60%153.03M |
| Add:Begin period cash and cash equivalents | 736.57%3.47B | 736.57%3.47B | 14.00%2.45B | 14.04%2.45B | -80.69%415.38M | -80.69%415.38M | 386.71%2.15B | 386.39%2.15B | 386.71%2.15B | 386.71%2.15B |
| End period cash equivalent | 574.83%2.25B | 667.88%2.82B | 41.68%3.47B | 70.48%3.83B | -84.03%332.81M | -84.05%367.6M | 14.00%2.45B | 34.49%2.25B | 157.56%2.08B | 387.10%2.3B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified opinion | -- | -- | -- | Disclaimer of Opinion | -- | -- | -- |
| Auditor | -- | -- | Dahua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.